Reference
National Institute for Health and Care Excellence (NICE). Patients with rare bile duct cancer set to benefit from life extending treatment. Internet Document : 27 Jul 2021. Available from: URL: https://www.nice.org.uk/news/article/patients-with-rare-bile-duct-cancer-set-to-benefit-from-life-extending-treatment
Rights and permissions
About this article
Cite this article
NICE: pemigatinib accepted for some bile duct cancer patients in final draft guidance. PharmacoEcon Outcomes News 884, 31 (2021). https://doi.org/10.1007/s40274-021-7938-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-7938-y